| Year |
Citation |
Score |
| 2023 |
Gong J, Kim DM, Freeman MR, Kim H, Ellis L, Smith B, Theodorescu D, Posadas E, Figlin R, Bhowmick N, Freedland SJ. Genetic and biological drivers of prostate cancer disparities in Black men. Nature Reviews. Urology. PMID 37964070 DOI: 10.1038/s41585-023-00828-w |
0.406 |
|
| 2023 |
Gong J, Kim DM, De Hoedt AM, Bhowmick N, Figlin R, Kim HL, Sandler H, Theodorescu D, Posadas E, Freedland SJ. Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300949. PMID 37890125 DOI: 10.1200/JCO.23.00949 |
0.38 |
|
| 2023 |
Borah S, Mishra R, Dey S, Suchanti S, Bhowmick NA, Giri B, Haldar S. Corrigendum to "Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism" [Mitochondrion 71 (2023) 40-49]. Mitochondrion. 71: 63. PMID 37276794 DOI: 10.1016/j.mito.2023.05.006 |
0.322 |
|
| 2023 |
Borah S, Mishra R, Dey S, Suchanti S, Bhowmick NA, Giri B, Haldar S. Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism. Mitochondrion. 71: 40-49. PMID 37211294 DOI: 10.1016/j.mito.2023.05.005 |
0.334 |
|
| 2023 |
Bhowmick N, Posadas E, Ellis L, Freedland SJ, Vizio DD, Freeman MR, Theodorescu D, Figlin R, Gong J. Targeting Glutamine Metabolism in Prostate Cancer. Frontiers in Bioscience (Elite Edition). 15: 2. PMID 36959101 DOI: 10.31083/j.fbe1501002 |
0.417 |
|
| 2022 |
Mishra R, Haldar S, Biondi S, Bhari VK, Singh G, Bhowmick NA. TGF-β controls stromal telomere length through epigenetic modifications. 3 Biotech. 12: 290. PMID 36276465 DOI: 10.1007/s13205-022-03346-5 |
0.451 |
|
| 2022 |
Bhowmick S, Bhowmick NA. RARγ: The Bone of Contention for Endothelial Cells in Prostate Cancer Metastasis. Cancer Research. 82: 2975-2976. PMID 36052494 DOI: 10.1158/0008-5472.CAN-22-2251 |
0.372 |
|
| 2022 |
Smith BN, Mishra R, Billet S, Placencio-Hickok VR, Kim M, Zhang L, Duong F, Madhav A, Scher K, Moldawer N, Oppenheim A, Angara B, You S, Tighiouart M, Posadas EM, ... Bhowmick NA, et al. Antagonizing CD105 and Androgen Receptor to Target Stromal-Epithelial Interactions for Clinical Benefit. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36045587 DOI: 10.1016/j.ymthe.2022.08.019 |
0.321 |
|
| 2022 |
Zhang L, Billet S, Gonzales G, Rohena-Rivera K, Muranaka H, Chu GC, Yang Q, Kim H, Bhowmick NA, Smith B. Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner. Cancers. 14. PMID 35884514 DOI: 10.3390/cancers14143449 |
0.385 |
|
| 2021 |
LeVee A, Lin CY, Posadas E, Figlin R, Bhowmick NA, Di Vizio D, Ellis L, Rosser CJ, Freeman MR, Theodorescu D, Freedland SJ, Gong J. Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. Oncotargets and Therapy. 14: 4819-4832. PMID 34552338 DOI: 10.2147/OTT.S315170 |
0.328 |
|
| 2021 |
Smith B, Kim S, Tighiouart M, Posadas E, Chung L, Figlin R, Bhowmick N, Gong J. Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification. Oncology (Williston Park, N.Y.). 35: 528-535. PMID 34524771 DOI: 10.46883/ONC.2021.3509.0528 |
0.318 |
|
| 2021 |
Gong J, Posadas E, Bhowmick N, Kim H, Daskivich T, Gupta A, Sandler H, Kamrava M, Zumsteg Z, Freedland S, Figlin R. Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics. Oncology (Williston Park, N.Y.). 35: 119-125. PMID 33818052 DOI: 10.46883/ONC.2021.3503.0119 |
0.387 |
|
| 2020 |
Salem AF, Gambini L, Billet S, Sun Y, Oshiro H, Zhao M, Hoffman RM, Bhowmick NA, Pellecchia M. Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model. Cancers. 12. PMID 33023262 DOI: 10.3390/cancers12102854 |
0.459 |
|
| 2020 |
Borah S, Bhowmick NA. The adaptor protein SHCA launches cancer invasion. The Journal of Biological Chemistry. 295: 10560-10561. PMID 32737145 DOI: 10.1074/Jbc.H120.014283 |
0.424 |
|
| 2020 |
Adashek JJ, Reed JP, Tandon A, Freedland SJ, Posadas E, Bhowmick N, Chung LW, Freeman M, Figlin RA, Gong J. Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment? Clinical Genitourinary Cancer. PMID 32631766 DOI: 10.1016/J.Clgc.2020.05.003 |
0.453 |
|
| 2020 |
Bhowmick NA, Oft J, Dorff T, Pal S, Agarwal N, Figlin RA, Posadas EM, Freedland S, Gong J. COVID-19 and androgen targeted therapy for prostate cancer patients. Endocrine-Related Cancer. PMID 32508311 DOI: 10.1530/Erc-20-0165 |
0.509 |
|
| 2020 |
Haldar S, Mishra R, Billet S, Thiruvalluvan M, Placencio-Hickok VR, Madhav A, Duong F, Angara B, Agarwal P, Tighiouart M, Posadas EM, Bhowmick NA. Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 32238563 DOI: 10.1073/Pnas.1910952117 |
0.492 |
|
| 2020 |
Vidal AC, Duong F, Howard LE, Wiggins E, Freedland SJ, Bhowmick NA, Gong J. Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer. Anticancer Research. 40: 1459-1462. PMID 32132043 DOI: 10.21873/Anticanres.14088 |
0.448 |
|
| 2019 |
Placencio-Hickok VR, Kato M, Bhowmick NA. 3D Co-culture System of Mouse Prostatic Wild-type Fibroblasts withHuman Prostate Cancer Epithelial Cells. Bio-Protocol. 9: e3225. PMID 33655012 DOI: 10.21769/BioProtoc.3225 |
0.381 |
|
| 2019 |
Cheng R, Billet S, Liu C, Haldar S, Choudhury D, Tripathi M, Hav M, Merchant A, Hu T, Huang H, Zhou H, Bhowmick NA. Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells. Oncogene. PMID 31685946 DOI: 10.1038/S41388-019-1084-Z |
0.369 |
|
| 2019 |
Placencio-Hickok VR, Madhav A, Kim S, Duong F, Angara B, Liu Z, Bhowmick NA. Soluble CD105 is prognostic of disease recurrence in prostate cancer patients. Endocrine-Related Cancer. PMID 31648185 DOI: 10.1530/Erc-19-0370 |
0.484 |
|
| 2019 |
Mishra R, Haldar S, Suchanti S, Bhowmick NA. Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocrine-Related Cancer. PMID 31627186 DOI: 10.1530/Erc-19-0347 |
0.479 |
|
| 2019 |
Mishra R, Bhowmick NA. Visualization of Macropinocytosis in Prostate Fibroblasts. Bio-Protocol. 9. PMID 31475219 DOI: 10.21769/BioProtoc.3235 |
0.366 |
|
| 2019 |
Ohashi K, Wang Z, Yang YM, Billet S, Tu W, Pimienta M, Cassel SL, Pandol SJ, Lu SC, Sutterwala FS, Bhowmick N, Seki E. NLRC4 inflammasome regulates the growth of colon cancer liver metastasis in non-alcoholic fatty liver disease. Hepatology (Baltimore, Md.). PMID 31044438 DOI: 10.1002/Hep.30693 |
0.313 |
|
| 2019 |
Brennen WN, Schweizer MT, Wang H, Bivalacqua TJ, Partin AW, Lim SJ, Chapman C, Abdallah R, Levy O, Bhowmick NA, Karp JM, De Marzo A, Isaacs JT, Denmeade SR. In Reply to the Letter to the Editor from Raj et al.: Clinical Evidence Indicates Allogeneic Mesenchymal Stem Cells Do Not Pose a Significant Risk for Cancer Progression in the Context of Cell-Based Drug Delivery. Stem Cells Translational Medicine. PMID 30925030 DOI: 10.1002/Sctm.19-0068 |
0.301 |
|
| 2019 |
Feng Y, Sessions EH, Zhang F, Ban F, Placencio-Hickok V, Ma CT, Zeng FY, Pass I, Terry DB, Cadwell G, Bankston LA, Liddington RC, Chung TDY, Pinkerton AB, Sergienko E, ... ... Bhowmick N, et al. Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells. Cancer Letters. PMID 30771432 DOI: 10.1016/J.Canlet.2019.02.012 |
0.447 |
|
| 2019 |
Schweizer MT, Wang H, Bivalacqua TJ, Partin AW, Lim SJ, Chapman C, Abdallah R, Levy O, Bhowmick NA, Karp JM, De Marzo A, Isaacs JT, Brennen WN, Denmeade SR. A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. Stem Cells Translational Medicine. PMID 30735000 DOI: 10.1002/Sctm.18-0230 |
0.433 |
|
| 2019 |
Tripathi M, Nandana S, Huang J, Kato M, Mishra R, Chung L, Xin L, Bhowmick N. Abstract 5164: Signaling crosstalk within prostate tumor microenvironment mediates castrate resistant disease progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5164 |
0.47 |
|
| 2018 |
Kato M, Placencio-Hickok VR, Madhav A, Haldar S, Tripathi M, Billet S, Mishra R, Smith B, Rohena-Rivera K, Agarwal P, Duong F, Angara B, Hickok D, Liu Z, Bhowmick NA. Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene. PMID 30177832 DOI: 10.1038/S41388-018-0461-3 |
0.411 |
|
| 2018 |
Edderkaoui M, Chheda C, Soufi B, Zayou F, Hu R, Ramanujan VK, Pan X, Boros LG, Tajbakhsh J, Madhav A, Bhowmick N, Wang Q, Lewis M, Tuli R, Habtezion A, et al. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Gastroenterology. PMID 30144430 DOI: 10.1053/J.Gastro.2018.08.028 |
0.366 |
|
| 2018 |
Cavassani KA, Meza RJ, Habiel DM, Chen JF, Montes A, Tripathi M, Martins GA, Crother TR, You S, Hogaboam CM, Bhowmick N, Posadas EM. Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells. Cancer Medicine. PMID 30094958 DOI: 10.1002/Cam4.1695 |
0.523 |
|
| 2018 |
Mishra R, Haldar S, Placencio V, Madhav A, Rohena-Rivera K, Agarwal P, Duong F, Angara B, Tripathi M, Liu Z, Gottlieb RA, Wagner S, Posadas EM, Bhowmick NA. Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming. The Journal of Clinical Investigation. PMID 30047926 DOI: 10.1172/Jci99397 |
0.807 |
|
| 2018 |
Madhav A, Andres A, Duong F, Mishra R, Haldar S, Liu Z, Angara B, Gottlieb R, Zumsteg ZS, Bhowmick NA. Antagonizing CD105 enhances radiation sensitivity in prostate cancer. Oncogene. PMID 29717261 DOI: 10.1038/S41388-018-0278-0 |
0.358 |
|
| 2018 |
Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, et al. Regulation of inside-out β1-integrin activation by CDCP1. Oncogene. PMID 29511352 DOI: 10.1038/S41388-018-0142-2 |
0.503 |
|
| 2018 |
Salem AF, Wang S, Billet S, Chen JF, Udompholkul P, Gambini L, Baggio C, Tseng HR, Posadas EM, Bhowmick NA, Pellecchia M. A potent EphA2 agonistic peptide-drug conjugate reduces circulating cancer cells and metastases in breast cancer models. Journal of Medicinal Chemistry. PMID 29470068 DOI: 10.1021/Acs.Jmedchem.7B01837 |
0.362 |
|
| 2018 |
Cavassani KA, Meza R, Habiel D, Chen J, Montes A, Tripathi M, Martins G, Crother TR, Hogaboam CM, You S, Bhowmick N, Posadas E. Abstract B086: Monocytes-produced Chitinase-3-like 1 is a driver of metastatic behavior in advanced prostate cancer patients Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B086 |
0.502 |
|
| 2018 |
Cavassani KA, Meza RJ, Habiel DM, Chen J, Montes A, Tripathi M, Martins GA, Crother TR, You S, Hogaboam CM, Bhowmick N, Posadas EM. Abstract 5208: Monocyte-produced Chitinase-3-like 1 is a driver of metastatic behavior in prostate cancer patients Cancer Research. 78: 5208-5208. DOI: 10.1158/1538-7445.Am2018-5208 |
0.489 |
|
| 2018 |
Yin L, Chu GC, Wang R, Madhav A, Yin L, Bhowmick N, Zhau HE, Zhou Q, Chung LWK. Abstract 1267: A novel mitochondria-based targeting to restore therapeutic responsiveness in cisplatin- and geftinib-resistant human lung cancer cells Prevention and Research. DOI: 10.1158/1538-7445.Am2018-1267 |
0.304 |
|
| 2017 |
Tripathi M, Nandana S, Billet S, Cavassani KA, Mishra R, Chung LWK, Posadas EM, Bhowmick NA. Modulation of cabozantinib efficacy by the prostate tumor microenvironment. Oncotarget. 8: 87891-87902. PMID 29152128 DOI: 10.18632/Oncotarget.21248 |
0.435 |
|
| 2017 |
Recouvreux MV, Wu B, Gao AC, Zonis S, Chesnokova V, Bhowmick N, Chung LW, Melmed S. Androgen receptor regulation of local growth hormone in prostate cancer cells. Endocrinology. PMID 28444169 DOI: 10.1210/En.2016-1939 |
0.506 |
|
| 2017 |
Smith B, Agarwal P, Bhowmick NA. MicroRNA applications for prostate, ovarian, and breast cancer in the era of precision medicine. Endocrine-Related Cancer. PMID 28289080 DOI: 10.1530/Erc-16-0525 |
0.447 |
|
| 2017 |
Han B, Bhowmick N, Qu Y, Chung S, Giuliano AE, Cui X. FOXC1: an emerging marker and therapeutic target for cancer. Oncogene. PMID 28288141 DOI: 10.1038/Onc.2017.48 |
0.352 |
|
| 2017 |
Minciacchi VR, Spinelli C, Reis-Sobreiro M, Cavallini L, You S, Zandian M, Li X, Chiarugi P, Adam RM, Posadas EM, Viglietto G, Freeman MR, Cocucci E, Bhowmick NA, Di Vizio D. MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer. Cancer Research. PMID 28202510 DOI: 10.1158/0008-5472.Can-16-2942 |
0.553 |
|
| 2017 |
Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW. Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Research. PMID 28108510 DOI: 10.1158/0008-5472.Can-16-0497 |
0.491 |
|
| 2017 |
Posadas EM, Chen J, Tripathi M, Lu Y, Montes A, Go A, Ureno A, Cavassani KA, Sievert M, Rogatko A, Limvorasak S, Oppenheim A, Moldawer NP, Chung LW, Bhowmick N, et al. Circulating tumor cell subsets and macrophage polarization to predict efficacy of cabozantinib in advanced prostate cancer with visceral metastases. Journal of Clinical Oncology. 35: 5031-5031. DOI: 10.1200/Jco.2017.35.15_Suppl.5031 |
0.393 |
|
| 2016 |
Levy O, Brennen WN, Han E, Rosen DM, Musabeyezu J, Safaee H, Ranganath S, Ngai J, Heinelt M, Milton Y, Wang H, Bhagchandani SH, Joshi N, Bhowmick N, Denmeade SR, et al. A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer. Biomaterials. 91: 140-150. PMID 27019026 DOI: 10.1016/J.Biomaterials.2016.03.023 |
0.459 |
|
| 2016 |
Smith BN, Bhowmick NA. Role of EMT in Metastasis and Therapy Resistance. Journal of Clinical Medicine. 5. PMID 26828526 DOI: 10.3390/Jcm5020017 |
0.496 |
|
| 2016 |
Bianchi-Frias D, Basom R, Delrow JJ, Coleman IM, Dakhova O, Qu X, Fang M, Franco OE, Ericson NG, Bielas JH, Hayward SW, True L, Morrissey C, Brown L, Bhowmick NA, et al. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations. Molecular Cancer Research : McR. PMID 26753621 DOI: 10.1158/1541-7786.Mcr-15-0330 |
0.453 |
|
| 2016 |
Meng X, Vander Ark A, Lee P, Hostetter G, Bhowmick NA, Matrisian LM, Williams BO, Miranti CK, Li X. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis. Oncogene. 35: 2370-8. PMID 26279296 DOI: 10.1038/Onc.2015.297 |
0.388 |
|
| 2016 |
Huynh R, Chen J, Tighiouart M, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, Scher K, Figlin RA, Posadas EM. A phase II study of cabozantinib in metastatic castration-resistant prostate cancer (mCRPC) with visceral metastases (VM) with very small nuclear circulating tumor cell (vsnCTC) association studies. Journal of Clinical Oncology. 34: 208-208. DOI: 10.1200/Jco.2016.34.2_Suppl.208 |
0.344 |
|
| 2016 |
Tripathi M, Nandana S, Huang J, Kato M, Chung LWK, Mishra R, Xin L, Bhowmick N. Abstract PR06: Reciprocal prostate cancer signaling with its microenvironment mediates castrate-resistant disease progression Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr06 |
0.583 |
|
| 2016 |
Tripathi M, Nandana S, Billet S, Posadas EM, Chung LWK, Bhowmick NA. Abstract LB-274: Microenvironment mediates the efficacy of Cabozantinib in prostate cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-274 |
0.57 |
|
| 2016 |
Minciacchi V, Spinelli C, Reis-Sobreiro M, Zandian M, Adam RM, Posadas EM, Michael FR, Cocucci E, Bhowmick N, Vizio DD. Abstract LB-266: Large oncosomes reprogram prostate fibroblasts toward a pro-angiogenic phenotype Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-266 |
0.52 |
|
| 2016 |
Brennen N, Levy O, Han E, Rosen DM, Musabeyezu J, Safaee H, Ranganath S, Ngai J, Heinelt M, Billett S, Bhowmick N, Denmeade S, Karp J, Isaacs J. Abstract 2067: Attacking prostate cancer with a prodrug-doped cellular Trojan horse Cancer Research. 76: 2067-2067. DOI: 10.1158/1538-7445.Am2016-2067 |
0.515 |
|
| 2016 |
Cavassani K, Gururajan M, Sievert M, Duan P, Freeman M, Chu GC, Bhowmick N, Chung L, Posadas E. Abstract 177: Src family kinase Fyn promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer Cancer Research. 76: 177-177. DOI: 10.1158/1538-7445.Am2016-177 |
0.516 |
|
| 2016 |
KATO M, SASAKI T, ISHII K, MIKI M, NISHIKAWA K, ARIMA K, SHIRAISHI T, BHOWMICK N, SUGIMURA Y. MP62-16 THE EXPLORATION OF THE ORDER IN THE HETEROGENEITY OF PROSTATE CANCER-ASSOCIATED STROMA ENVIRONMENT. Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.924 |
0.492 |
|
| 2016 |
Dru C, Haldar S, Bhowmick N. Mp24-08 Epigenetic Regulation Of Dna Damage Repair Gene 8-Oxoguanine Dna Glycosylase (Ogg1) In The Pyroptosis Pathways Of Hemorrhagic Cystitis The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.764 |
0.328 |
|
| 2015 |
Arumuggam N, Bhowmick NA, Rupasinghe HP. A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer. Phytotherapy Research : Ptr. 29: 805-17. PMID 25787773 DOI: 10.1002/Ptr.5327 |
0.392 |
|
| 2015 |
Haldar S, Dru C, Choudhury D, Mishra R, Fernandez A, Biondi S, Liu Z, Shimada K, Arditi M, Bhowmick NA. Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent manner. The Journal of Biological Chemistry. 290: 6574-83. PMID 25596528 DOI: 10.1074/Jbc.M114.617886 |
0.31 |
|
| 2014 |
Posadas EM, Tighiouart M, Lu Y, Di Vizio D, Hoffman D, Green L, Scher K, Sievert M, Oppenheim A, Moldawer N, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, et al. 1574PA TRANSLATIONAL PHASE 2 STUDY OF CABOZANTINIB IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER WITH VISCERAL METASTASES WITH CHARACTERIZATION OF CIRCULATING TUMOR CELLS AND LARGE ONCOSOMES. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv547. PMID 28171512 DOI: 10.1093/Annonc/Mdu358.5 |
0.447 |
|
| 2014 |
Banerjee J, Mishra R, Li X, Jackson RS, Sharma A, Bhowmick NA. A reciprocal role of prostate cancer on stromal DNA damage. Oncogene. 33: 4924-31. PMID 24141771 DOI: 10.1038/Onc.2013.431 |
0.533 |
|
| 2014 |
Posadas EM, Tighgohart M, Lu Y, Vizio DD, Hoffman DMJ, Green L, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, et al. A translational phase 2 study of cabozantinib in men with metastatic castration resistant prostate cancer with visceral metastases with characterization of circulating tumor cells and large oncosomes. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E16080 |
0.515 |
|
| 2014 |
Brennen WN, Levy O, Ranganath S, Schweizer M, Rosen M, Billet S, Bhowmick N, Denmeade S, Karp J, Isaacs J. Abstract 699: Mesenchymal stem cells (MSC) as cell-based vectors for PSA-activated proaerolysin to sites of prostate cancer Cancer Research. 74: 699-699. DOI: 10.1158/1538-7445.Am2014-699 |
0.496 |
|
| 2014 |
Choudhury D, Haldar S, Bhowmick NA. Abstract 2868: Use of methionine metabolites in predicting recurrent prostate cancer affordably Cancer Research. 74: 2868-2868. DOI: 10.1158/1538-7445.Am2014-2868 |
0.499 |
|
| 2013 |
Morello M, Minciacchi VR, de Candia P, Yang J, Posadas E, Kim H, Griffiths D, Bhowmick N, Chung LW, Gandellini P, Freeman MR, Demichelis F, Di Vizio D. Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle (Georgetown, Tex.). 12: 3526-36. PMID 24091630 DOI: 10.4161/Cc.26539 |
0.446 |
|
| 2013 |
Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Fazil L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity. Cancer Cell. 23: 332-46. PMID 23518348 DOI: 10.1016/j.ccr.2013.02.016 |
0.526 |
|
| 2013 |
Zhang H, Berel D, Wang Y, Li P, Bhowmick NA, Figlin RA, Kim HL. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models. Plos One. 8: e54918. PMID 23349989 DOI: 10.1371/Journal.Pone.0054918 |
0.347 |
|
| 2013 |
Wang S, Noberini R, Stebbins JL, Das S, Zhang Z, Wu B, Mitra S, Billet S, Fernandez A, Bhowmick NA, Kitada S, Pasquale EB, Fisher PB, Pellecchia M. Targeted delivery of paclitaxel to EphA2-expressing cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 128-37. PMID 23155185 DOI: 10.1158/1078-0432.Ccr-12-2654 |
0.412 |
|
| 2013 |
Qi J, Tripathi M, Sahgal N, Fazil L, Ettinger S, Placzek WJ, Claps G, Chung LWK, Bowtell D, Gleave M, Bhowmick N, Ronai Z. Abstract 5456: The E3 ubiquitin ligase Siah2 regulates the androgen receptor activity and contributes to castration-resistant prostate cancer. Cancer Research. 73: 5456-5456. DOI: 10.1158/1538-7445.Am2013-5456 |
0.52 |
|
| 2012 |
Bhowmick NA. Metastatic ability: adapting to a tissue site unseen. Cancer Cell. 22: 563-4. PMID 23153528 DOI: 10.1016/J.Ccr.2012.10.011 |
0.41 |
|
| 2012 |
Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, ... Bhowmick NA, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. The American Journal of Pathology. 181: 1573-84. PMID 23022210 DOI: 10.1016/J.Ajpath.2012.07.030 |
0.423 |
|
| 2012 |
Jackson RS, Placzek W, Fernandez A, Ziaee S, Chu CY, Wei J, Stebbins J, Kitada S, Fritz G, Reed JC, Chung LW, Pellecchia M, Bhowmick NA. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. Neoplasia (New York, N.Y.). 14: 656-65. PMID 22904682 DOI: 10.1593/Neo.12640 |
0.548 |
|
| 2012 |
Tripathi M, Billet S, Bhowmick NA. Understanding the role of stromal fibroblasts in cancer progression. Cell Adhesion & Migration. 6: 231-5. PMID 22568983 DOI: 10.4161/Cam.20419 |
0.367 |
|
| 2012 |
Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Molecular Cancer Research : McR. 10: 494-503. PMID 22290877 DOI: 10.1158/1541-7786.Mcr-11-0506 |
0.57 |
|
| 2012 |
Chen M, Yeh CR, Chang HC, Vitkus S, Wen XQ, Bhowmick NA, Wolfe A, Yeh S. Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models. The Journal of Pathology. 226: 17-27. PMID 22069040 DOI: 10.1002/Path.2949 |
0.537 |
|
| 2012 |
Morello M, Dudley AC, Schow P, Adam RM, Morley S, Mulholland D, Insabato L, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR, Vizio DD. Abstract 430: MiRNA profiling of prostate cancer cell-derived large oncosomes identifies a signature of invasion and metastasis Cancer Research. 72: 430-430. DOI: 10.1158/1538-7445.Am2012-430 |
0.372 |
|
| 2012 |
Yeh C, Chen M, Chang H, Vitkus S, Wen X, Bhowmick N, Wolfe A, Messing EM, Yeh S. 1583 LOSS OF EPITHELIAL OESTROGEN RECEPTOR α INHIBITS OESTROGEN-STIMULATED PROSTATE PROLIFERATION AND SQUAMOUS METAPLASIA VIA IN VIVO TISSUE SELECTIVE KNOCKOUT MODELS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1355 |
0.536 |
|
| 2011 |
Stabler S, Koyama T, Zhao Z, Martinez-Ferrer M, Allen RH, Luka Z, Loukachevitch LV, Clark PE, Wagner C, Bhowmick NA. Serum methionine metabolites are risk factors for metastatic prostate cancer progression. Plos One. 6: e22486. PMID 21853037 DOI: 10.1371/Journal.Pone.0022486 |
0.491 |
|
| 2011 |
Kiskowski MA, Jackson RS, Banerjee J, Li X, Kang M, Iturregui JM, Franco OE, Hayward SW, Bhowmick NA. Role for stromal heterogeneity in prostate tumorigenesis. Cancer Research. 71: 3459-70. PMID 21444670 DOI: 10.1158/0008-5472.Can-10-2999 |
0.538 |
|
| 2011 |
Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson RS, Revelo MP, Bhowmick NA, Hayward SW. Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Research. 71: 1272-81. PMID 21303979 DOI: 10.1158/0008-5472.Can-10-3142 |
0.554 |
|
| 2011 |
Li X, Martinez-Ferrer M, Botta V, Uwamariya C, Banerjee J, Bhowmick NA. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness. Oncogene. 30: 167-77. PMID 20818421 DOI: 10.1038/Onc.2010.400 |
0.578 |
|
| 2011 |
Li X, Sterling JA, Mundy GR, Hayward SW, Matrisian LM, Bhowmick NA. Abstract 527: Loss of TGF-β responsiveness in stromal cells of the prostate facilitates early prostate cancer bone lesion development Cancer Research. 71: 527-527. DOI: 10.1158/1538-7445.Am2011-527 |
0.553 |
|
| 2011 |
Martinez-Ferrer M, Qi Y, Sanchez MM, Bhowmick NA. Abstract 391: Inflammatory mediators of prostate cancer metastasis Cancer Research. 71: 391-391. DOI: 10.1158/1538-7445.Am2011-391 |
0.54 |
|
| 2010 |
Placencio VR, Li X, Sherrill TP, Fritz G, Bhowmick NA. Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. Plos One. 5: e12920. PMID 20886110 DOI: 10.1371/Journal.Pone.0012920 |
0.806 |
|
| 2010 |
Ge L, Meng W, Zhou H, Bhowmick N. Could stroma contribute to field cancerization? Medical Hypotheses. 75: 26-31. PMID 20149555 DOI: 10.1016/J.Mehy.2010.01.019 |
0.355 |
|
| 2010 |
Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de Crombrugghe B, Davidson JM, Bhowmick NA. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. The American Journal of Pathology. 176: 98-107. PMID 19959810 DOI: 10.2353/Ajpath.2010.090283 |
0.366 |
|
| 2010 |
Placencio VR, Sherrill TP, Yu X, Bhowmick NA. Abstract 1955: Bone-marrow-derived cells incorporate into the prostate during regrowth Cancer Research. 70: 1955-1955. DOI: 10.1158/1538-7445.Am10-1955 |
0.778 |
|
| 2010 |
Banerjee J, Li X, Bhowmick NA. Abstract 1429: TGF-β mediates epigenetic regulation of DNA damage in the prostate cancer associated stroma Cancer Research. 70: 1429-1429. DOI: 10.1158/1538-7445.Am10-1429 |
0.568 |
|
| 2010 |
Jackson RS, Kiskowski M, Li X, Banerjee J, Hayward SW, Bhowmick NA. Abstract 1428: Necessary contribution of wild-type stroma to prostate tumorigenesis Cancer Research. 70: 1428-1428. DOI: 10.1158/1538-7445.Am10-1428 |
0.478 |
|
| 2010 |
Li X, Sterling JA, Banerjee J, Munoz S, Mundy GR, Bhowmick NA. Abstract 1418: Stromal cells of prostate, not the bone marrow, facilitate prostate cancer osteoblastic tumor growth in bone Cancer Research. 70: 1418-1418. DOI: 10.1158/1538-7445.Am10-1418 |
0.527 |
|
| 2010 |
Ge L, Meng W, Zhou H, Bhowmick N. Abstract 1015: Head and neck cancer expression of YAP65: A novel oncogene Cancer Research. 70: 1015-1015. DOI: 10.1158/1538-7445.Am10-1015 |
0.43 |
|
| 2009 |
Anumanthan G, Tanaka ST, Adams CM, Thomas JC, Wills ML, Adams MC, Hayward SW, Matusik RJ, Bhowmick NA, Brock JW, Pope JC. Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstruction. The Journal of Urology. 182: 1775-80. PMID 19692014 DOI: 10.1016/J.Juro.2009.05.126 |
0.371 |
|
| 2009 |
Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Ishii K, Hayward SW, Matusik RJ, Bhowmick NA. Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation; Research in Biological Diversity. 77: 95-102. PMID 19281768 DOI: 10.1016/J.Diff.2008.09.012 |
0.564 |
|
| 2009 |
Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA, Frelix G, Shappell S, Chen YH. Identification of extracellular delta-catenin accumulation for prostate cancer detection. The Prostate. 69: 411-8. PMID 19116988 DOI: 10.1002/Pros.20902 |
0.546 |
|
| 2008 |
Blum DL, Koyama T, M'Koma AE, Iturregui JM, Martinez-Ferrer M, Uwamariya C, Smith JA, Clark PE, Bhowmick NA. Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7790-7. PMID 19047106 DOI: 10.1158/1078-0432.Ccr-08-1716 |
0.505 |
|
| 2008 |
Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA. Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis Oncogene. 27: 7118-7130. PMID 18724388 DOI: 10.1038/Onc.2008.293 |
0.81 |
|
| 2008 |
Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Research. 68: 6762-9. PMID 18701501 DOI: 10.1158/0008-5472.Can-08-0107 |
0.541 |
|
| 2008 |
Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R. Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells. Cancer Research. 68: 6224-31. PMID 18676846 DOI: 10.1158/0008-5472.Can-08-0513 |
0.549 |
|
| 2008 |
Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Research. 68: 4709-18. PMID 18559517 DOI: 10.1158/0008-5472.Can-07-6289 |
0.817 |
|
| 2008 |
Jackson RS, Franco OE, Bhowmick NA. Gene targeting to the stroma of the prostate and bone. Differentiation; Research in Biological Diversity. 76: 606-23. PMID 18494814 DOI: 10.1111/J.1432-0436.2008.00273.X |
0.544 |
|
| 2008 |
Martinez-Ferrer M, Iturregui JM, Uwamariya C, Starkman J, Sharif-Afshar AR, Suzuki K, Visedsindh W, Matusik RJ, Dmochowski RR, Bhowmick NA. Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. The American Journal of Pathology. 172: 59-67. PMID 18079438 DOI: 10.2353/Ajpath.2008.070529 |
0.306 |
|
| 2008 |
Sterling J, Johnson R, Roberts A, Li X, Bhowmick N, Mundy G. P35. Wnt signaling regulates Gli2 expression in human breast cancer cells that cause osteolysis Cancer Treatment Reviews. 34: 26-27. DOI: 10.1016/J.Ctrv.2008.03.077 |
0.346 |
|
| 2007 |
Oottamasathien S, Williams K, Franco OE, Wills ML, Thomas JC, Sharif-Afshar AR, DeMarco RT, Brock JW, Bhowmick NA, Hayward SW, Pope JC. Urothelial inhibition of transforming growth factor-beta in a bladder tissue recombination model. The Journal of Urology. 178: 1643-9. PMID 17707033 DOI: 10.1016/J.Juro.2007.03.163 |
0.359 |
|
| 2007 |
Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R. Signaling pathways regulating TC21-induced tumorigenesis. The Journal of Biological Chemistry. 282: 27713-20. PMID 17656362 DOI: 10.1074/Jbc.M703037200 |
0.601 |
|
| 2007 |
Oottamasathien S, Wang Y, Williams K, Franco OE, Wills ML, Thomas JC, Saba K, Sharif-Afshar AR, Makari JH, Bhowmick NA, DeMarco RT, Hipkens S, Magnuson M, Brock JW, Hayward SW, et al. Directed differentiation of embryonic stem cells into bladder tissue. Developmental Biology. 304: 556-66. PMID 17289017 DOI: 10.1016/J.Ydbio.2007.01.010 |
0.319 |
|
| 2007 |
M'Koma AE, Blum DL, Norris JL, Koyama T, Billheimer D, Motley S, Ghiassi M, Ferdowsi N, Bhowmick I, Chang SS, Fowke JH, Caprioli RM, Bhowmick NA. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochemical and Biophysical Research Communications. 353: 829-34. PMID 17194448 DOI: 10.1016/J.Bbrc.2006.12.111 |
0.477 |
|
| 2006 |
Ao M, Williams K, Bhowmick NA, Hayward SW. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Research. 66: 8007-16. PMID 16912176 DOI: 10.1158/0008-5472.Can-05-4451 |
0.461 |
|
| 2006 |
Wang W, Huang XR, Canlas E, Oka K, Truong LD, Deng C, Bhowmick NA, Ju W, Bottinger EP, Lan HY. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circulation Research. 98: 1032-9. PMID 16556868 DOI: 10.1161/01.Res.0000218782.52610.Dc |
0.342 |
|
| 2005 |
Sharif-Afshar AR, Donohoe JM, Pope JC, Adams MC, Brock JW, Bhowmick NA. Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblasts. The Journal of Urology. 174: 1704-7; discussion 1. PMID 16148686 DOI: 10.1097/01.Ju.0000164720.72732.9C |
0.389 |
|
| 2005 |
Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene. 24: 5053-68. PMID 15856015 DOI: 10.1038/Sj.Onc.1208685 |
0.604 |
|
| 2005 |
Bhowmick NA, Moses HL. Tumor-stroma interactions. Current Opinion in Genetics & Development. 15: 97-101. PMID 15661539 DOI: 10.1016/J.Gde.2004.12.003 |
0.562 |
|
| 2005 |
Moses H, Cheng N, Chytil A, Gorska A, Aakre M, Forrester E, Neilson E, Bhowmick N. Stromal and epithelial TGF-β signaling in mammary tumorigenesis Breast Cancer Research. 7. DOI: 10.1186/Bcr1045 |
0.608 |
|
| 2004 |
Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 432: 332-7. PMID 15549095 DOI: 10.1038/Nature03096 |
0.556 |
|
| 2004 |
Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (New York, N.Y.). 303: 848-51. PMID 14764882 DOI: 10.1126/Science.1090922 |
0.611 |
|
| 2004 |
Brown K, Bhowmick NA. Linking TGF-beta-mediated Cdc25A inhibition and cytoskeletal regulation through RhoA/p160(ROCK) signaling. Cell Cycle (Georgetown, Tex.). 3: 408-10. PMID 14752278 DOI: 10.4161/Cc.3.4.778 |
0.391 |
|
| 2004 |
Sharif‐Afshar A, Gorska AE, Neilson EG, Davidson JM, Moses HL, Bhowmick NA. 071 TGF?�?Mediated Paracrine Regulation of Keratinocyte Wound Closure Wound Repair and Regeneration. 12: A20-A20. DOI: 10.1111/J.1067-1927.2004.0Abstractbr.X |
0.54 |
|
| 2004 |
Bhowmick NA, Kasper S. 603: Prostate Androgen Responsiveness Involve Stromal Transforming Growth Factor-Beta Signaling The Journal of Urology. 171: 160-160. DOI: 10.1016/S0022-5347(18)37865-0 |
0.514 |
|
| 2004 |
Bhowmick NA, Moses HL. 413: The Conditional Knock-Out of Transforming Growth Factor-Beta Signaling in the Prostate Stroma Results in Prostate Intraepithelial Neoplasia Journal of Urology. 171: 109-109. DOI: 10.1016/S0022-5347(18)37675-4 |
0.669 |
|
| 2004 |
Donohoe JM, Pope JC, Bhowmick NA, Adams MC, Brock JW, Hayward SW. 171: Expression of Dominant Active Transforming Growth Factor-Beta Receptor in Fetal Rat Bladder Stromal Cells The Journal of Urology. 171: 45-46. DOI: 10.1016/S0022-5347(18)37433-0 |
0.368 |
|
| 2003 |
Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL. TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proceedings of the National Academy of Sciences of the United States of America. 100: 15548-53. PMID 14657354 DOI: 10.1073/Pnas.2536483100 |
0.581 |
|
| 2003 |
Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA, Moses HL. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Research : Bcr. 5: R187-98. PMID 14580254 DOI: 10.1186/Bcr640 |
0.573 |
|
| 2003 |
Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. The American Journal of Pathology. 163: 1539-49. PMID 14507660 DOI: 10.1016/S0002-9440(10)63510-9 |
0.565 |
|
| 2003 |
Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia (New York, N.Y.). 5: 267-77. PMID 12869309 DOI: 10.1016/S1476-5586(03)80058-1 |
0.681 |
|
| 2003 |
Saha D, Bhowmick NA, Cao C, Kim J, Sekhar KR, Freeman ML, Choy H. P-349 Flavopiridol prevented transforming growth factor-beta-mediated epithelial to mesenchymal transdifferentiation Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)92317-8 |
0.351 |
|
| 2001 |
Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin β1 Signaling is Necessary for Transforming Growtn Factor-β Activation of p38MAPK and Epithelial Plasticity Journal of Biological Chemistry. 276: 46707-46713. PMID 11590169 DOI: 10.1074/Jbc.M106176200 |
0.553 |
|
| 2001 |
Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism Molecular Biology of the Cell. 12: 27-36. PMID 11160820 DOI: 10.1091/Mbc.12.1.27 |
0.571 |
|
| 2000 |
Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. The Journal of Biological Chemistry. 275: 36803-10. PMID 10969078 DOI: 10.1074/Jbc.M005912200 |
0.561 |
|
| Show low-probability matches. |
